TIBCS 2021

Program

Time (UTC+8) Topic Speaker Moderator Abstract Slides Video
08:00 - 08:15 The beauty of Taiwan
Ling-Ming Tseng
08:15 - 08:30 Opening Remarks
Ling-Ming Tseng
Wen-Je Ko
Ta-Sen Yeh
08:30 - 09:10 Quantitative Medicine for Breast Cancer Patients
Charles M. Perou
Ling-Ming Tseng
Chi-Cheng Huang
09:10 - 09:40 Immunotherapy for TNBC
Hope S. Rugo
Yen-Shen Lu
Yi-Fang Tsai
09:40 - 10:10 CDK 4/6 inhibitors: Are the differences clinically meaningful?
Dennis Slamon
Chiun-Sheng Huang
Lo Chiao
10:40 - 11:30 【TBCS-GBCC Joint Session】Issue about How to adapt the updated modern treatment for Asian patients-Part (I)
Chiun-Sheng Huang
Ching-Hung Lin
Byung Joo Chae
Hiroji Iwata
Jeong Eon Lee
Wen-Ling Kuo
Masakazu, Toi
Seho Park
Soo Chin Lee
Yoon-Sim Yap
Chun-Yu Liu
Ling-Ming Tseng
Yen-Shen Lu
11:30 - 12:20 【TBCS-GBCC Joint Session】Issue about How to adapt the updated modern treatment for Asian patients-Part (II)
Chiun-Sheng Huang
Ching-Hung Lin
Byung Joo Chae
Hiroji Iwata
Jeong Eon Lee
Wen-Ling Kuo
Masakazu, Toi
Seho Park
Soo Chin Lee
Yoon-Sim Yap
Chun-Yu Liu
Ling-Ming Tseng
Yen-Shen Lu
12:20 - 13:00 Considerations of the management of Asian postmenopausal women with ER+/HER2- advanced breast cancer
Wei-Pang Chung
Ming-Feng Hou
Chin-Hua Tsai
13:30 - 14:00 The changing treatment landscape for premenopausal women with advanced breast cancer
Hsu-Huan Chou
Hong-Tai Chang
Ta-Chung Chao
14:00 - 14:30 What tumor biology makes the difference in patients treated with CDK4/6 inhibitors?
Eva Ciruelos
Shin-Cheh Chen
Ming-Yang Wang
14:30 - 15:00 Tyrosine kinase inhibitors for brain metastasis in HER2-positive breast cancer
Volkmar Müller
Kuan-Te Li
Huan-Ming Hsu
15:30 - 16:00 Management of early breast cancer in patients with germline BRCA mutations
Karen Gelmon
Fang-Ming Chen
Chih-Chiang Hung
16:00 - 16:30 Combination treatment strategy for TNBC-state of the art and the future
Rebecca Dent
Tsu-Yi Chao
Dah-Cherng Yeh
16:30 - 17:00 Non-industry sponsored clinical trials for breast cancer: past, present, and future
Michael Gnant
King-Jen Chang
Kuo-Ting Lee
17:10 - 17:40 Trastuzumab biosimilars in oncology – data for ABP980 and real-world experience
Hans-Christian Kolberg
Chia-Ming Hsieh
Hsien-Tang Yeh
Time (UTC+8) Topic Speaker Moderator Abstract Slides Video
08:30 - 09:00 Applications on AI-enhanced breast imaging
Katja Pinker-Domenig
Tsen-Long Yang
Jane Wang
09:00 - 09:30 Multimodal response assessment to neoadjuvant treatment
Katja Pinker-Domenig
Wen-Hung Kuo
Ming-Hsin Yeh
09:30 - 10:00 Transforming clinical treatment in HER2 positive breast cancer with the new subcutaneous dosage
Sara M. Tolaney
Jyh-Cherng Yu
Shih-Che Shen
10:00 - 10:30 The progress of antibody drug conjugate treatment for HER2 positive breast cancer
Shanu Modi
Yao-Lung Kuo
Hsien-Kun Chang
11:00 - 11:25 Optimal choice of adjuvant chemotherapy regimen for EBC
Ming-Shen Dai
Shou-Tung Chen
Chao-Ming Hung
11:25 - 11:50 Strategies emerge for chemotherapy de-escalation in early breast cancer
Dwan-Ying Chang
Fiona Tsui-Fen Cheng
Liang-Chih Liu
11:50 - 12:30 Outshined salvage therapy for advanced breast cancer
Kun-Ming Rau
Hwei-Chung Wang
Chung-Chin Yao
12:30 - 12:55 Potential predictive value of PIK3CA and ESR1 by liquid biopsy NGS for late-line hormone-based therapies in ER+/HER2-metastatic breast cancer (MBC)
Wei-Wu Chen
Yao-Jen Chang
Shih-Hsin Tu
13:20 - 13:45 Neomargin- surgical clip for tumor localization after Neoadjuvant chemotherapy
Chung-Liang Li
Frank Fu Ou-Yang
Chin-Sheng Hung
13:45 - 14:15 Knowledge gaps in oncoplastic surgery
Florian Fitzal
Dar-Ren Chen
Hung-Wen Lai
14:15 - 14:45 Pathological evaluation of axillary lymph nodes in breast cancer
Puay Hoon Tan
Shyr-Ming Sheen-Chen
Cheng-Ping Yu
15:15 - 15:40 Accelerated partial breast irradiation for early breast cancer: current status and future trends
Sung-Hsin Kuo
Jeng-Fong Chiou
Shen-Liang Shih
15:40 - 16:15 Radiologists’ expectations for help from AI when reading mammograms
László Tabár
King-Jen Chang
Hsiu-Hsi Chen
16:15 - 17:15 After TIBCS 2021 What will you do for your patients tomorrow
Chieh-Han Chuang
Chen-Hsiang Chang
I-Chun Chen
Jiun-I Lai
Guo-Shiou Liao
Yen-Dun Tzeng
Fang-Ming Chen
Ching-Hung Lin
17:15 - 17:30 Award ceremony & closing
Ling-Ming Tseng
Fang-Ming Chen